A strategy combining Prostate Imaging Reporting and Data System and prostate-specific antigen density was superior to MRI-based risk models in safely reducing unnecessary biopsies without missing c... Background In validation studies, risk models for clinically significant prostate cancer (csPCa; Gleason score ≥3+4) combining multiparametric MRI and clinical factors have demonstrated poor calibr...